TAL
VRNA

TIG Advisors LLC’s Verona Pharma VRNA Stock Holding History

TIG Advisors LLC’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-635,267
Closed -$67.8M – 112
2025
Q3 		$67.8M Buy
+635,267
New +$66.3M 4.02% 6

Other funds holding VRNA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

TIG Advisors LLC's VRNA Position: Q4 2025 in Review

TIG Advisors LLC sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 635,267 shares — an estimated $67.8M sold.

TIG Advisors LLC first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $67.8M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

  • TIG Advisors LLC reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
  • TIG Advisors LLC sold 635,267 Verona Pharma shares in Q4 2025, an estimated $67.8M.
  • TIG Advisors LLC first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
  • TIG Advisors LLC's Verona Pharma position peaked at $67.8M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on TIG Advisors LLC's 13F filing for Q4 2025, filed 17 Feb 2026.